Evidence map›Paper›PMID 34769431›Full record

ArticleInternational journal of molecular sciences2021

Description of Release Process of Doxorubicin from Modified Carbon Nanotubes.

Dorota Chudoba, Monika Jażdżewska, Katarzyna Łudzik, Sebastian Wołoszczuk, Ewa Juszyńska-Gałązka, Mikołaj Kościński

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Dorota ChudobaFaculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland.ORCID 0000-0002-2469-3046
Monika JażdżewskaFaculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland.ORCID 0000-0002-9957-7832
Katarzyna ŁudzikFrank Laboratory of Neutron Physics, Joint Institute for Nuclear Research, 141980 Dubna, Russia.ORCID 0000-0003-1749-808X
Sebastian WołoszczukFaculty of Physics, Adam Mickiewicz University, 61-614 Poznan, Poland.ORCID 0000-0003-0249-0907
Ewa Juszyńska-GałązkaInstitute of Nuclear Physics Polish Academy of Sciences, 31-342 Kraków, Poland.ORCID 0000-0002-3964-0721
Mikołaj KościńskiDepartment of Physics and Biophysics, Faculty of Food Science and Nutrition, University of Life Sciences, 60-637 Poznan, Poland.ORCID 0000-0003-0569-3312
Joint Institute for Nuclear Research · RUAdam Mickiewicz University in Poznań · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLUniversity of Life Sciences in Poznań · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The article discusses the release process of doxorubicin hydrochloride (DOX) from multi-wall carbon nanotubes (MWCNTs). The studies described a probable mechanism of release and actions between the surface of functionalized MWCNTs and anticancer drugs. The surface of carbon nanotubes (CNTs) has been modified via treatment in nitric acid to optimize the adsorption and release process. The modification efficiency and physicochemical properties of the MWCNTs+DOX system were analyzed by using SEM, TEM, EDS, FTIR, Raman Spectroscopy and UV-Vis methods. Based on computer simulations at pH 7.4 and the experiment at pH 5.4, the kinetics and the mechanism of DOX release from MWNT were discussed. It has been experimentally observed that the acidic pH (5.4) is appropriate for the efficient release of the drug from CNTs. It was noted that under acidic pH conditions, which is typical for the tumour microenvironment almost 90% of the drug was released in a relatively short time. The kinetics models based on different mathematical functions were used to describe the release mechanism of drugs from MWCNTs. Our studies indicated that the best fit of experimental kinetic curves of release has been observed for the Power-law model and the fitted parameters suggest that the drug release mechanism of DOX from MWCNTs is controlled by Fickian diffusion. Molecular dynamics simulations, on the other hand, have shown that in a neutral pH solution, which is close to the blood pH, the release process does not occur keeping the aggregation level constant. The presented studies have shown that MWCNTs are promising carriers of anticancer drugs that, depending on the surface modification, can exhibit different adsorption mechanisms and release.

Indexed as

Antineoplastic AgentsDoxorubicinDrug Delivery SystemsDrug LiberationHydrogen-Ion ConcentrationKineticsMolecular Dynamics SimulationNanotubes, CarbonSpectrum Analysis, RamanAntineoplastic AgentsDoxorubicinNanotubes, Carbondoxorubicindrug deliverydrug release mechanismkinetics of releasemodified carbon nanotubes

Identifiers

PMID34769431
PMCPMC8584310
OpenAlexW3213705875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.